Dirk Van Raemdonck is an expert in Surgery at Universitair Ziekenhuis Leuven (Belgium). As of October 2026, ScienceLeadR ranks Dirk Van Raemdonck in the top 1% of experts worldwide for Lung Transplantation and Reperfusion Injury. Dirk Van Raemdonck has authored 801 publications, the most recent in 2026, and is an investigator in 5 clinical trials. SLR score: 2,148 (community average: 125). How the SLR is computed.

LeadR Profile

Dirk Van Raemdonck Universitair Ziekenhuis Leuven Belgium
2 148 ScienceLeadR Reputation 2148
Network Map

Surgery

Subspecialties: Transplantation - Pulmonology - Thoracic And Cardiovascular Surgery

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Short Biography

Prof dr Dirk Van Raemdonck is consultant thoracic surgeon in the department of thoracic surgery at the University Hospitals Leuven and emeritus professor in the department of chronic diseases and metabolism at the KU Leuven University, Leuven, Belgium.

He is the former surgical director of the Leuven Lung Transplant Group until his retirement on 1st October 2024. He was responsible for an annual volume of about 60-70 lung transplants over the last 5 years and a total of nearly 1500 lung transplants since 1991. He served as the head of the Leuven Transplant Center until September 2024.

He is ESTS past-president and honorary member and current president of the UEMS Section of Thoracic Surgery.

Current positions:

  1. chair of the Board of Supervision of Eurotransplant International Foundation, Leiden, the Netherlands since January 2022.
  2. president of the Royal Academy for Medicine in Belgium since January 2023.
  3. editor-in-chief of the Journal for Heart and Lung Transplantation Open since April 2023.
  4. Vice-president International Thymic Malignancy Interest Group 2025


Organizations

Career arc: 1994 - 2026

Source: PubMed

Universitair Ziekenhuis Leuven

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Lower lung donor PaO 2/FiO 2 ratio correlates with early primary graft dysfunction, but does not impact overall survival after lung transplantation: a dual center study.
PMID 42920666 — lung, incidence, primary graft dysfunction, risk factors, transplants, lung transplantation, transplantation
Transpl Int20260
Very late recurrence of thymoma after 14 years: an International Thymic Malignancy Interest Group Tumor Board case report from a Turkish multidisciplinary team.
PMID 42763666 — margins of excision, thymoma, neoplasms, drug therapy, therapeutics, chemotherapy
Mediastinum20260
A rare giant large cell neuroendocrine carcinoma: an ITMIG Tumor Board case report from a Turkish multidisciplinary team.
PMID 42763668 — cells, neoplasms, combined modality therapy, neuroendocrine cells, therapeutics, carcinoma, neuroendocrine
Mediastinum20260
A Comprehensive Approach to Lung Volume Reduction Encompassing Surgical and Endobronchial Treatment of Severe Emphysema.
PMID 42548516 — lung, emphysema, therapeutics
CHEST Pulm20254
Effect of surgical exposure on outcomes in bilateral lung transplantation: insight from the international multicenter extracorporeal life support (ECLS) in lung transplantation registry.
PMID 42526777 — registries, lung, extracorporeal membrane oxygenation, graft survival, heart transplantation, transplants, sternotomy, lung transplantation, transplantation
J Heart Lung Transplant20260

Clinical Studies 5

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 4
Phase 4 1

By status:

Completed 5

By type:

Interventional 4
Observational 1

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 1
multicentricup10 2

Main Topics

LeadR Networks

Main global connection map